Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AMPE > SEC Filings for AMPE > Form 8-K on 4-Oct-2013All Recent SEC Filings

Show all filings for AMPIO PHARMACEUTICALS, INC.

Form 8-K for AMPIO PHARMACEUTICALS, INC.


4-Oct-2013

Entry into a Material Definitive Agreement, Change in Directors or Pr


Item 1.01 Entry into a Material Definitive Agreement.

The information set forth under Item 5.02 of this Current Report on Form 8-K is hereby incorporated in this Item 1.01 by reference.



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 4, 2013, Ampio Pharmaceuticals, Inc. (the "Company") entered into an amendment to the Employment Agreement, effective January 9, 2012, with Michael Macaluso, the Chief Executive Officer of the Company (the "Macaluso Amendment"). Under the Macaluso Amendment, Mr. Macaluso's annual compensation was increased to $300,000, effective October 1, 2013.

At its meeting on October 1, 2013, the Compensation Committee of the Board of Directors of the Company approved a one-time bonus in the amount of $150,000 as compensation for Mr. Macaluso in recognition of his strong leadership and performance in connection with the $25 million financing transaction announced on September 26, 2013.

The description of the Macaluso Amendment set forth herein does not purport to be complete and is qualified in its entirety by reference to the full text thereof, which is attached hereto as Exhibit 10.1.



Item 9.01 Financial Statements and Exhibits.

Exhibit
Number                                    Description

10.1         Amendment to Employment Agreement between Ampio Pharmaceuticals, Inc.
             and Michael Macaluso, dated October 4, 2013


  Add AMPE to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AMPE - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.